-
Bovine Insulin in Metabolic Cell Culture Workflows
2026-09-22
Bovine insulin provides a controlled metabolic background for cell proliferation, glucose-handling, and inhibitor-response studies. This guide combines practical formulation advice with the ROS–PDK–PDH mechanism reported in melanoma research, while clearly separating validated findings from workflow recommendations.
-
Adamtsl3, MMP9, and Perineuronal-Net Plasticity
2026-09-22
This study identifies Adamtsl3 as a cell-autonomous regulator of perineuronal-net integrity in parvalbumin interneurons and links its loss to elevated MMP9 activity, oxidative stress, and renewed adult cortical plasticity. The findings provide a mechanistic framework for studying extracellular-matrix control in schizophrenia-related neurobiology and for designing targeted MMP9 perturbation experiments.
-
Novobiocin Sodium: From Gyrase to Translation
2026-09-21
A mechanistic and translational perspective on Novobiocin Sodium, linking bacterial DNA gyrase inhibition with DNA damage research, antibiotic resistance studies, and emerging in vitro antiparasitic evidence against Toxoplasma gondii.
-
Sabutoclax Workflow for Pan-Bcl-2 Studies
2026-09-21
Sabutoclax supports mechanism-focused studies of apoptosis, proliferation, and drug response across cancer cell models. A time-resolved workflow that separates growth inhibition from true cell killing can make its broad Bcl-2 family activity easier to interpret and translate.
-
Coronavirus Macrodomains and PARP-Mediated Antiviral Defense
2026-09-20
The reference study shows that coronavirus macrodomains counter host ADP-ribosylation by preventing PARP12- and PARP14-dependent restriction of viral replication and enhancement of interferon expression. Its combination of pharmacological inhibition, targeted knockdown, primary macrophage infection, and mouse studies provides a useful framework for interpreting PARP perturbation experiments in antiviral research.
-
Gepotidacin and the Gyrase Cleavage Mechanism
2026-09-19
Gibson et al. defined how gepotidacin inhibits Staphylococcus aureus gyrase through potent catalytic inhibition and a cleavage pattern that differs from fluoroquinolones. The study combines biochemical assays with crystal structures to show how stable, predominantly single-stranded cleavage complexes may provide a distinct strategy for antibacterial discovery.
-
SAN–Cardiac Plexus Assembloids Model Maturation
2026-09-19
The reference study develops human pluripotent stem cell-derived assembloids that combine sinoatrial node, cardiac ganglionated plexus, and atrial-like tissues to model innervation-associated pacemaker maturation. By integrating electrophysiology, organoid-based functional assays, and human SAN spatial transcriptomics, the authors identify a prosaposin–GPR37 neuron-to-pacemaker signaling program with potential relevance to conduction disease research.
-
Trim71–Ago2 Control of let-7 and Stem Cell Pluripotency
2026-09-18
The eLife study shows that Trim71 maintains mouse embryonic stem-cell pluripotency by repressing Ago2 mRNA translation, thereby limiting the post-transcriptional accumulation of mature let-7 microRNAs. Its findings define Ago2 availability as a regulatory link in the Trim71–let-7 bistable switch and provide a mechanistic framework for studying cytoplasmic control of stem-cell fate.
-
Methoxy-X04 for Amyloid-β Imaging in AD
2026-09-17
Methoxy-X04 is a brain-permeable fluorescent amyloid beta probe for amyloid beta fibril detection and aggregate imaging in Alzheimer’s disease research. Its nanomolar fibril affinity and reported 30–60 minute in vivo imaging window support plaque and cerebrovascular amyloid visualization in transgenic mouse models.
-
I-BET151 Workflows for Cancer Biology
2026-09-17
Build reproducible BET-inhibition experiments with I-BET151 (GSK1210151A), from dose-response and apoptosis assays to chromatin-linked validation. The workflow also shows how to use this reversible chemical probe to test whether the super-enhancer–FOXA1–SLC7A11 circuit identified in prostate cancer is sensitive to BET-dependent transcriptional control.
-
Shh–FGF Signaling in Guinea Pig and Mouse Penile Development
2026-09-17
This Cells study explains why guinea pigs form a fully open urethral groove whereas mice develop a largely canalized urethral plate, linking the difference to species-specific expression of Shh, Fgf10, and Fgfr2. Its comparative anatomy, gene-expression analysis, and ex vivo perturbation experiments provide a useful framework for interpreting developmental signaling and its limits across animal models.
-
Cefiderocol Activity Against Resistant Enterobacterales
2026-09-16
This European surveillance study directly compared cefiderocol with approved and developmental β-lactam/β-lactamase inhibitor combinations across 1,909 Enterobacterales isolates, including meropenem-resistant and multidrug-resistant subsets. Its resistance-mechanism analysis shows why cefiderocol susceptibility testing may add clinically useful information, particularly when carbapenem and β-lactam/β-lactamase inhibitor options are limited.
-
Hyaluronic Acid Scaffolds for Diabetic Wound Healing
2026-09-15
The reference study develops a porous acellular dermal matrix scaffold that combines hyaluronic acid, polydopamine nanoparticles, and deferoxamine mesylate with near-infrared photothermal treatment. Its findings link extracellular-matrix-like architecture, sustained pro-angiogenic delivery, and localized warming to improved vascularization and diabetic wound repair.
-
GLP-1 (9-36) amide: Assay Workflow Guide
2026-09-15
Build more interpretable GLP-1 receptor signaling experiments with a practical antagonist workflow, from peptide handling to cAMP assay controls. The guide emphasizes solubility-aware preparation, receptor cross-talk controls, and translational applications in metabolic regulation studies.
-
Bacterial HTS Assay for AKU HGD Chaperones
2026-09-14
The reference study developed a robust Escherichia coli assay for screening pharmacological chaperones that can restore activity to missense variants of human homogentisate 1,2-dioxygenase (HGD), the defective enzyme in alkaptonuria. Screening 2,320 approved drugs identified 30 compounds that increased activity of the HGDG161R variant, establishing a practical framework for variant-aware drug repositioning and follow-up mechanistic studies.